Respiratory Disease Testing/Diagnostics Market - Forecast(2024 - 2030)

Report Code: HCR 75469 Report Format: PDF + Excel
Respiratory Disease Testing/Diagnostics Market size in 2019 is estimated to be $5.9 billion, growing at a CAGR of 5% during the forecast period 2020-2025. Respiratory disease is the disease that affects the lungs and respiratory system. It is caused by infection, smoking tobacco, or air pollution. Asthma, chronic obstructive pulmonary disease (COPD), and lung cancer are some of the major respiratory diseases. The growing geriatric population with respiratory disorders and technological advancement in respiratory diagnostic testing are the major factors driving the growth of the market. Moreover, increasing prevalence of respiratory disease linked to increased rates of tobacco smoking is set to further influence the overall market growth for respiratory disease testing/diagnostics.

Key Takeaways
  • In 2019, North America dominated the respiratory disease testing/diagnostics market owing to the growing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease, and technological advancement in respiratory diagnostic system.
  • The growing geriatric population and technological advancement are likely to aid in the market growth of respiratory disease testing/diagnostics.
  • Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market are provided in the Respiratory Disease Testing/Diagnostics Market report.
  • The high cost associated with diagnosis and testing creates a hurdle for the growth of the market. 

By Test Type - Segment Analysis
Based on the test type, the Respiratory Disease Testing/Diagnostics market is segmented into Mechanical Test, Imaging Test, Traditional Diagnostics Test, and In-Vitro Diagnostics Test. The Imaging Test is forecast to be the fastest-growing segment and is estimated to grow at a CAGR of 4.8% during the forecast period 2020-2025. This is mainly owing to the rapid development and adoption of innovative technologies. Moreover, it provides a better diagnosis at affordable health care expenses and is safe as well as effective. The common tests are the spirometry test that is to measure lung function, the methacholine challenge test to help detect asthma, and computed tomography that provides an image of the chest.

By End-Use - Segment Analysis
Based on the End-Use, Respiratory Disease Testing/Diagnosis market is segmented into clinical laboratories, hospitals, physician clinics, diagnostic centers, Ambulatory Surgical Centers, Home Care Facilities and others. In 2019, Hospitals held the largest share in the respiratory disease testing/diagnostics market. This is mainly owing to rising demand for efficient and effective results, shorter recovery time. Moreover, the availability of advanced technology and experienced doctors in hospitals is contributing to the growth of this segment.

By Geography - Segment Analysis
North America dominated the health and hygiene market share accounting for 36% of the market in 2019. This is mainly owing to the growing prevalence of respiratory diseases such as asthma, and chronic obstructive pulmonary diseases here. According to World Health Organization, an estimated 65 million people have moderate to severe chronic obstructive pulmonary disease and about 334 million people suffer from asthma, which is the most common chronic disease of childhood that affects 14% of children in North America. Also, the healthcare facilities and technological advances in North America further enhance the dominance of this region.
However, the Asia Pacific region is anticipated to be the fastest-growing during the forecast period 2020-2025. This is mainly owing to improving healthcare infrastructure and rising patient awareness regarding the availability of diagnostic procedures. 

Drivers –Respiratory Disease Testing/Diagnostics Market 

  • Rise in Geriatric Population
The rise in geriatric population across the globe is a major factor in the growth of respiratory disease testing/diagnostics market. According to the World Health Organization, 8.7 million people suffering from TB across the globe, and 50 million people fight with occupational lung disease. The chronic obstructive pulmonary disease has become the third leading cause of death worldwide. Moreover, the growing number of people suffering from chronic diseases such as asthma, pneumonia are contributing to the growth of the market.

  • Technological Advancements
Technological Advancements and innovation in the respiratory diagnostic system are driving the growth of the market. Adoption of the latest innovation such as monitoring technology, and electronic inhalers are contributing to the growth. Moreover, increasing awareness towards treatment in both developed and developing countries are also contributing to the growth of this market during the forecast period 2020-2025.

Challenges – Respiratory Disease Testing/Diagnostics Market 
The high cost associated with diagnosis and testing creates a hurdle for the growth of the market. Moreover, strict regulatory requirements and reimbursement concerns are also restraining the growth of the market. Also, the increased cost associated with diagnostic testing equipment and testing procedures is also restraining the market growth.

Respiratory Disease Testing/Diagnostics Industry Outlook
Product launches, Merger & Acquisitions, Joint Ventures and R&D activities are key strategies adopted by players in the respiratory disease testing/diagnosis market. Respiratory disease testing/diagnosis top 10 companies are Koninklijke Philips N.V., Thermo fisher Scientific Inc., Medtronic, Smiths Group Plc, Bio-Rad Laboratories Inc., 3M Companywil, Astrazeneca, Haier Inc., MGC Diagnostics Corporation, British Diagnostics and COSMED. 

Developments:
  • On 22 May 2017, Philips acquired Respiratory Technologies Inc., to improve its respiratory care portfolio and support their home care and hospital partners as well as improve their respiratory care business.
  • On 16 December 2019, Medtronic plc and Christiana Care announced a collaboration to improve outcomes for Christiana Care patients. Medtronic and Christiana are working to standardize an enhanced respiratory monitoring initiative.

1. Respiratory Disease Testing/Diagnostics Market Overview
    1.1 Definitions and Scope
2. Respiratory Disease Testing/Diagnostics Market- Executive Summary
    2.1 Market Size and Key Trends by Company
    2.2 Key trends by Product & Service
    2.3 Key trends by Test Type
    2.4 Key trends by Disease
    2.5 Key trends by End-Use 
    2.6 Key trends by Geography
3. Respiratory Disease Testing/Diagnostics Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis - Key Companies
    3.5 Pricing Analysis
4. Respiratory Disease Testing/Diagnostics Market - Startup companies Scenario Premium (Premium)
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Respiratory Disease Testing/Diagnostics Market - Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Respiratory Disease Testing/Diagnostics Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power Of Suppliers
        6.3.2 Bargaining Powers Of Customers
        6.3.3 Threat Of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat Of Substitutes 
7. Respiratory Disease Testing/Diagnostics Market - Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Respiratory Disease Testing/Diagnostics Market– By Product & Service (Market Size -$Million/$Billion)
    8.1 Instruments & Devices
    8.2 Kits & Reagents
    8.3 Services & Software
9. Respiratory Disease Testing/Diagnostics Market– By Test Type (Market Size -$Million/$Billion)
    9.1 Mechanical Test
        9.1.1 Spirometry
        9.1.2 Peak Flow Test
        9.1.3 OSA Diagnostics Test
        9.1.4 Others
    9.2 Imaging Test
        9.2.1 X-Ray
        9.2.2 Computed Tomography
        9.2.3 Magnetic Resonance Imaging
        9.2.4 Others
    9.3 Traditional Diagnostics Test
        9.3.1 Immunodiagnostics
        9.3.2 Biochemical Characterization
        9.3.3 Microscopy
        9.3.4 Others
    9.4 In-Vitro Diagnostics Test
        9.4.1 Point-of-Care Test
        9.4.2 Molecular Diagnostics Test
        9.4.3 Nuclei Diagnostic Test
        9.4.4 In Situ Hybridization
        9.4.5 DNA Sequencing
        9.4.6 Blood Gas Test
        9.4.7 Respiratory Measurement
        9.4.8 Others
10. Respiratory Disease Testing/Diagnostics Market– By Disease (Market Size -$Million/$Billion)
    10.1 Asthma
    10.2 Chronic Obstructive Pulmonary Disease
    10.3 Lung Cancer
    10.4 Tuberculosis
    10.5 Acute Respiratory Infection
    10.6 Others
11. Respiratory Disease Testing/Diagnostics Market– By End-Use (Market Size -$Million/$Billion)
    11.1 Clinical Laboratories
    11.2 Hospitals
    11.3 Physician Clinics
    11.4 Ambulatory Surgical Centers
    11.5 Home Care Facilities
    11.6 Others
12. Respiratory Disease Testing/Diagnostics Market- By Geography (Market Size -$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K.
        12.2.2 Germany
        12.2.3 France
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 Japan
        12.3.3 South Korea
        12.3.4 India
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia-Pacific
    12.4 Rest of the World
        12.4.1 Middle East
        12.4.2 Africa
        12.4.3 South America
13. Respiratory Disease Testing/Diagnostics Market– Entropy
14. Respiratory Disease Testing/Diagnostics Market- Industry / Segment Competition landscape Premium (Premium)
    14.1 Market Share Analysis
        14.1.1 Market Share by Region- Key companies
        14.1.2 Market Share at Global Level- Key companies
        14.1.3 Best Practices for Companies
15. Respiratory Disease Testing/Diagnostics Market- Key Company List by Country Premium (Premium)
16. Respiratory Disease Testing/Diagnostics Market Company Analysis
    16.1 Company Revenue, Products, M&A, Developments
    16.2 Company 1
    16.3 Company 2
    16.4 Company 3
    16.5 Company 4
    16.6 Company 5
    16.7 Company 6
    16.8 Company 7
    16.9 Company 8
    16.10 Company 9
    16.11 Company 10 and more
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Respiratory Disease Testing:Product Estimate Trend Analysis Market 2023-2030 ($M)
1.1 Imaging Test Market 2023-2030 ($M) - Global Industry Research
1.1.1 Market Estimate Segment Forecast Market 2023-2030 ($M)
1.2 Respiratory Measurement Device Market 2023-2030 ($M) - Global Industry Research
1.2.1 Market Estimate Market 2023-2030 ($M)
1.2.2 Pulse Oximetry System Market 2023-2030 ($M)
1.2.3 Capnographs Market 2023-2030 ($M)
1.2.4 Spirometer Market 2023-2030 ($M)
1.2.5 Peak Flowmeters Market 2023-2030 ($M)
1.3 Blood Gas Test Market 2023-2030 ($M) - Global Industry Research
2.Global Respiratory Disease Testing:End-Use Estimate Trend Analysis Market 2023-2030 ($M)
2.1 Hospital Market 2023-2030 ($M) - Global Industry Research
2.2 Physician Clinic Market 2023-2030 ($M) - Global Industry Research
2.3 Clinical Laboratory Market 2023-2030 ($M) - Global Industry Research
3.Global Respiratory Disease Testing:Product Estimate Trend Analysis Market 2023-2030 (Volume/Units)
3.1 Imaging Test Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 Market Estimate Segment Forecast Market 2023-2030 (Volume/Units)
3.2 Respiratory Measurement Device Market 2023-2030 (Volume/Units) - Global Industry Research
3.2.1 Market Estimate Market 2023-2030 (Volume/Units)
3.2.2 Pulse Oximetry System Market 2023-2030 (Volume/Units)
3.2.3 Capnographs Market 2023-2030 (Volume/Units)
3.2.4 Spirometer Market 2023-2030 (Volume/Units)
3.2.5 Peak Flowmeters Market 2023-2030 (Volume/Units)
3.3 Blood Gas Test Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global Respiratory Disease Testing:End-Use Estimate Trend Analysis Market 2023-2030 (Volume/Units)
4.1 Hospital Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Physician Clinic Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Clinical Laboratory Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Respiratory Disease Testing:Product Estimate Trend Analysis Market 2023-2030 ($M)
5.1 Imaging Test Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Market Estimate Segment Forecast Market 2023-2030 ($M)
5.2 Respiratory Measurement Device Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Market Estimate Market 2023-2030 ($M)
5.2.2 Pulse Oximetry System Market 2023-2030 ($M)
5.2.3 Capnographs Market 2023-2030 ($M)
5.2.4 Spirometer Market 2023-2030 ($M)
5.2.5 Peak Flowmeters Market 2023-2030 ($M)
5.3 Blood Gas Test Market 2023-2030 ($M) - Regional Industry Research
6.North America Respiratory Disease Testing:End-Use Estimate Trend Analysis Market 2023-2030 ($M)
6.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
6.2 Physician Clinic Market 2023-2030 ($M) - Regional Industry Research
6.3 Clinical Laboratory Market 2023-2030 ($M) - Regional Industry Research
7.South America Respiratory Disease Testing:Product Estimate Trend Analysis Market 2023-2030 ($M)
7.1 Imaging Test Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Market Estimate Segment Forecast Market 2023-2030 ($M)
7.2 Respiratory Measurement Device Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Market Estimate Market 2023-2030 ($M)
7.2.2 Pulse Oximetry System Market 2023-2030 ($M)
7.2.3 Capnographs Market 2023-2030 ($M)
7.2.4 Spirometer Market 2023-2030 ($M)
7.2.5 Peak Flowmeters Market 2023-2030 ($M)
7.3 Blood Gas Test Market 2023-2030 ($M) - Regional Industry Research
8.South America Respiratory Disease Testing:End-Use Estimate Trend Analysis Market 2023-2030 ($M)
8.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
8.2 Physician Clinic Market 2023-2030 ($M) - Regional Industry Research
8.3 Clinical Laboratory Market 2023-2030 ($M) - Regional Industry Research
9.Europe Respiratory Disease Testing:Product Estimate Trend Analysis Market 2023-2030 ($M)
9.1 Imaging Test Market 2023-2030 ($M) - Regional Industry Research
9.1.1 Market Estimate Segment Forecast Market 2023-2030 ($M)
9.2 Respiratory Measurement Device Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Market Estimate Market 2023-2030 ($M)
9.2.2 Pulse Oximetry System Market 2023-2030 ($M)
9.2.3 Capnographs Market 2023-2030 ($M)
9.2.4 Spirometer Market 2023-2030 ($M)
9.2.5 Peak Flowmeters Market 2023-2030 ($M)
9.3 Blood Gas Test Market 2023-2030 ($M) - Regional Industry Research
10.Europe Respiratory Disease Testing:End-Use Estimate Trend Analysis Market 2023-2030 ($M)
10.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
10.2 Physician Clinic Market 2023-2030 ($M) - Regional Industry Research
10.3 Clinical Laboratory Market 2023-2030 ($M) - Regional Industry Research
11.APAC Respiratory Disease Testing:Product Estimate Trend Analysis Market 2023-2030 ($M)
11.1 Imaging Test Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Market Estimate Segment Forecast Market 2023-2030 ($M)
11.2 Respiratory Measurement Device Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Market Estimate Market 2023-2030 ($M)
11.2.2 Pulse Oximetry System Market 2023-2030 ($M)
11.2.3 Capnographs Market 2023-2030 ($M)
11.2.4 Spirometer Market 2023-2030 ($M)
11.2.5 Peak Flowmeters Market 2023-2030 ($M)
11.3 Blood Gas Test Market 2023-2030 ($M) - Regional Industry Research
12.APAC Respiratory Disease Testing:End-Use Estimate Trend Analysis Market 2023-2030 ($M)
12.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
12.2 Physician Clinic Market 2023-2030 ($M) - Regional Industry Research
12.3 Clinical Laboratory Market 2023-2030 ($M) - Regional Industry Research
13.MENA Respiratory Disease Testing:Product Estimate Trend Analysis Market 2023-2030 ($M)
13.1 Imaging Test Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Market Estimate Segment Forecast Market 2023-2030 ($M)
13.2 Respiratory Measurement Device Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Market Estimate Market 2023-2030 ($M)
13.2.2 Pulse Oximetry System Market 2023-2030 ($M)
13.2.3 Capnographs Market 2023-2030 ($M)
13.2.4 Spirometer Market 2023-2030 ($M)
13.2.5 Peak Flowmeters Market 2023-2030 ($M)
13.3 Blood Gas Test Market 2023-2030 ($M) - Regional Industry Research
14.MENA Respiratory Disease Testing:End-Use Estimate Trend Analysis Market 2023-2030 ($M)
14.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
14.2 Physician Clinic Market 2023-2030 ($M) - Regional Industry Research
14.3 Clinical Laboratory Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
2.Canada Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
3.Mexico Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
4.Brazil Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
5.Argentina Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
6.Peru Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
7.Colombia Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
8.Chile Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
9.Rest of South America Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
10.UK Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
11.Germany Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
12.France Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
13.Italy Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
14.Spain Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
15.Rest of Europe Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
16.China Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
17.India Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
18.Japan Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
19.South Korea Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
20.South Africa Respiratory Disease Testing/Diagnostics Market Revenue, 2023-2030 ($M)
21.North America Respiratory Disease Testing/Diagnostics By Application
22.South America Respiratory Disease Testing/Diagnostics By Application
23.Europe Respiratory Disease Testing/Diagnostics By Application
24.APAC Respiratory Disease Testing/Diagnostics By Application
25.MENA Respiratory Disease Testing/Diagnostics By Application
26.Becton Dickinson Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Geographic Foothold, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Koninklijke Philip N V, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Resmed, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Fischer Paykel, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Medtronic, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Mgc Diagnostics Corporation And Subsidiary, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Carestream Medical, Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)